Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Allaart

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Annals of the Rheumatic Diseases|May 10, 2011
Simplified versions of the original disease activity score: validation in the BeSt trialR Koevoets, N B Klarenbeek, M Güler-Yüksel, et al.
Osteoarthritis and Cartilage|August 10, 2010
Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritisM Güler-Yüksel, C F Allaart, I Watt, et al.
Annals of the Rheumatic Diseases|April 26, 2007
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|December 1, 2010
A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt studyE van der Kooi, N B Klarenbeek, M Güler-Yüksel, et al.
Clinical Rheumatology|December 11, 2012
Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategyL Dirven, N B Klarenbeek, M van den Broek, et al.
Annals of the Rheumatic Diseases|April 1, 2008
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritisM Güler-Yüksel, C F Allaart, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|January 22, 2009
DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritisY P M Goekoop-Ruiterman, J K de Vries-Bouwstra, P J S M Kerstens, et al.
Annals of the Rheumatic Diseases|July 9, 2010
Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximabN B Klarenbeek, M Güler-Yüksel, D M F M van der Heijde, et al.
Annals of the Rheumatic Diseases|October 22, 2008
Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritisS M van der Kooij, S le Cessie, Y P M Goekoop-Ruiterman, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Annals of the Rheumatic Diseases|May 10, 2011
Simplified versions of the original disease activity score: validation in the BeSt trialR Koevoets, N B Klarenbeek, M Güler-Yüksel, et al.
Osteoarthritis and Cartilage|August 10, 2010
Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritisM Güler-Yüksel, C F Allaart, I Watt, et al.
Annals of the Rheumatic Diseases|April 26, 2007
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|July 24, 2007
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|December 1, 2010
A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt studyE van der Kooi, N B Klarenbeek, M Güler-Yüksel, et al.
Clinical Rheumatology|December 11, 2012
Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategyL Dirven, N B Klarenbeek, M van den Broek, et al.
Annals of the Rheumatic Diseases|April 1, 2008
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritisM Güler-Yüksel, C F Allaart, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|January 22, 2009
DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritisY P M Goekoop-Ruiterman, J K de Vries-Bouwstra, P J S M Kerstens, et al.
Annals of the Rheumatic Diseases|July 9, 2010
Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximabN B Klarenbeek, M Güler-Yüksel, D M F M van der Heijde, et al.
Annals of the Rheumatic Diseases|October 22, 2008
Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritisS M van der Kooij, S le Cessie, Y P M Goekoop-Ruiterman, et al.
Pageof 9